News

Moderna gets $50 million to develop mRNA Ebola vaccine against Bundibugyo

Moderna has received $50 million to develop an mRNA Ebola vaccine targeting the Bundibugyo strain. The funding comes as health officials work to urgently accelerate vaccine development amid a raging Ebola outbreak.

The mRNA vaccine platform allows for rapid development and production compared to traditional vaccine methods. This approach has been successfully applied in COVID-19 vaccines and is now being adapted to combat Ebola.

Sources